HEW Pharma SRL
1.3 FTEHEW Pharma reported total assets of €1.01m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026), with 1.3 full-time equivalent.
The score of HEW Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets +41 % Headcount (avg FTE) -28 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HEW Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 28 Oct 2024
- Year ended 31 Dec 2022filed on 31 Oct 2023
- Year ended 31 Dec 2021filed on 29 Sep 2022
HEW Pharma's financial analysis
- Solvency27.7%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HEW Pharma
HEW Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.590.393
- VAT number
- BE0681590393
- Peppol
- Registered · 0208:0681590393 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2017
- Registered office
- 2920 Kalmthout
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Manufacture of medicaments (NACE 21201)
HEW Pharma (SRL) has been based in Kalmthout since 2017, active in: manufacture of medicaments. For 2025, it reports a net profit of 30,396 € and equity of 279,177 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.7%, below the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to HEW Pharma
Companies in the same business, of comparable size and area, outside its group.
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Kokuma Wholesale of perfume and cosmetics Charleroi · balance sheet 659,798 €
- Lophar Retail sale of pharmaceutical products Aalter · balance sheet €1.33m
- Fortilab Manufacture of pharmaceutical preparations Etterbeek · balance sheet €1.39m
- A.M.'s Manufacture of perfume and toilet preparations Schaerbeek · balance sheet €1.02m
- Laboratoire DIPO Manufacture of perfume and toilet preparations Etterbeek · balance sheet 24,259 €
- Jovilux Wholesale of perfume and cosmetics Oudenaarde · balance sheet 929,444 €
- Aphrodites Amphora Cosmetics Manufacture of perfume and toilet preparations Wevelgem · balance sheet 950,692 €
Frequently asked questions about HEW Pharma
What is the revenue of HEW Pharma?
HEW Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HEW Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0681590393 for HEW Pharma, if the company is VAT-registered. Its company number (CBE) is 0681.590.393.
Where is the registered office of HEW Pharma?
According to the CBE register, the registered office of HEW Pharma is in 2920 Kalmthout.
What is the equity of HEW Pharma?
At the close of the 2025 financial year, the equity of HEW Pharma amounts to 279,177 €, a solvency of 27.7% of total assets.
How many people work at HEW Pharma?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages HEW Pharma?
The register lists 4 active mandates at HEW Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HEW Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →